Which trial do we need? A global, adaptive, platform trial to reduce death and disability from tuberculous meningitis.
Journal article
Thwaites GE. et al, (2023), Clin Microbiol Infect
Correction: A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.
Journal article
Mai NTH. et al, (2023), Elife, 12
MUC5AC genetic variation is associated with tuberculous meningitis CSF cytokine responses and mortality.
Journal article
Sabo MC. et al, (2023), J Infect Dis
The Personalised Randomized Controlled Trial: Evaluation of a new trial design.
Journal article
Lee KM. et al, (2023), Stat Med
Distribution and origins of Mycobacterium tuberculosis L4 in Southeast Asia.
Journal article
Ashton PM. et al, (2023), Microb Genom, 9
Monkeypox Virus Infection in 2 Female Travelers Returning to Vietnam from Dubai, United Arab Emirates, 2022.
Journal article
Dung NT. et al, (2023), Emerg Infect Dis, 29
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for Hepatitis C: a single arm mechanistic pilot study
Journal article
Flower B. et al, (2023), eLife, 12
Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis.
Journal article
Ardiansyah E. et al, (2023), medRxiv
Correction: Aetiology and Potential Animal Exposure in Central Nervous System Infections in Vietnam.
Journal article
Brindle HE. et al, (2022), EcoHealth
Expert Review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic.
Journal article
Solante R. et al, (2022), Expert review of vaccines
Kinetics of Neutralizing Antibodies against Omicron Variant in Vietnamese Healthcare Workers after Primary Immunization with ChAdOx1-S and Booster Immunization with BNT162b2.
Journal article
Chau NVV. et al, (2022), The American journal of tropical medicine and hygiene
Aetiology and Potential Animal Exposure in Central Nervous System Infections in Vietnam.
Journal article
Brindle HE. et al, (2022), EcoHealth
Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing ofM. tuberculosis
Journal article
(2022), European Respiratory Journal, 60, 2200239 - 2200239
Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicenter cohort.
Journal article
Escrihuela-Vidal F. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients.
Journal article
Tran HNH. et al, (2022), NPJ biofilms and microbiomes, 8
Expert review on global real-world vaccine effectiveness against SARS-CoV-2.
Journal article
Chuenkitmongkol S. et al, (2022), Expert review of vaccines, 21, 1255 - 1268
Linezolid for Drug-Resistant Tuberculosis.
Journal article
Thwaites G. and Nguyen NV., (2022), The New England journal of medicine, 387, 842 - 843
A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics
Journal article
(2022), PLOS Biology, 20, e3001721 - e3001721
Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms
Journal article
(2022), PLOS Biology, 20, e3001755 - e3001755
Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated cohorts.
Journal article
Camp J. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 28, 1149.e1 - 1149.e9